Profound Medical Corp. (TSX:PRN)
8.34
+0.04 (0.48%)
Apr 2, 2025, 12:21 PM EST
Profound Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 54.91 | 26.21 | 46.52 | 67.15 | 83.91 | Upgrade
|
Cash & Short-Term Investments | 54.91 | 26.21 | 46.52 | 67.15 | 83.91 | Upgrade
|
Cash Growth | 109.48% | -43.65% | -30.73% | -19.97% | 466.98% | Upgrade
|
Accounts Receivable | 6.43 | 6.75 | 5.84 | 1.41 | 6.45 | Upgrade
|
Other Receivables | 0.62 | 0.53 | 0.51 | - | 0.99 | Upgrade
|
Receivables | 7.05 | 7.29 | 6.34 | 1.41 | 7.43 | Upgrade
|
Inventory | 5.8 | 6.99 | 7.94 | 7.41 | 5.33 | Upgrade
|
Prepaid Expenses | 1.31 | 1.41 | 1.22 | 1.15 | 1.07 | Upgrade
|
Total Current Assets | 69.07 | 41.9 | 62.02 | 77.13 | 97.74 | Upgrade
|
Property, Plant & Equipment | 0.82 | 1.57 | 1.72 | 1.9 | 2.28 | Upgrade
|
Goodwill | - | - | - | 2.69 | 2.68 | Upgrade
|
Other Intangible Assets | 0.26 | 0.49 | 0.68 | 1.44 | 1.9 | Upgrade
|
Long-Term Accounts Receivable | - | - | - | 3.62 | - | Upgrade
|
Long-Term Deferred Tax Assets | 0.09 | - | - | - | - | Upgrade
|
Total Assets | 70.23 | 43.96 | 64.42 | 86.78 | 104.6 | Upgrade
|
Accounts Payable | 1.32 | 0.87 | 2.03 | 3.18 | 3.38 | Upgrade
|
Accrued Expenses | 2.84 | 2.42 | - | - | - | Upgrade
|
Current Portion of Long-Term Debt | 1.74 | 2.1 | 0.52 | - | - | Upgrade
|
Current Portion of Leases | 0.26 | 0.26 | 0.24 | 0.25 | 0.31 | Upgrade
|
Current Income Taxes Payable | - | - | 0.3 | - | 0.01 | Upgrade
|
Current Unearned Revenue | 0.42 | 0.72 | 0.47 | 0.48 | 0.36 | Upgrade
|
Other Current Liabilities | - | - | 0.62 | 0.25 | 0.74 | Upgrade
|
Total Current Liabilities | 6.57 | 6.37 | 4.18 | 4.16 | 4.81 | Upgrade
|
Long-Term Debt | 2.92 | 5 | 6.65 | - | - | Upgrade
|
Long-Term Leases | 0.2 | 0.5 | 0.82 | 1.13 | 1.36 | Upgrade
|
Long-Term Unearned Revenue | 0.05 | 0.73 | 0.76 | 0.88 | 1.08 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | 0.06 | - | - | - | Upgrade
|
Other Long-Term Liabilities | 0.07 | 0.07 | - | - | - | Upgrade
|
Total Liabilities | 9.81 | 12.73 | 12.42 | 6.16 | 7.25 | Upgrade
|
Common Stock | 281.55 | 222.21 | 205.83 | 219.58 | 211.53 | Upgrade
|
Additional Paid-In Capital | 21.3 | 20.81 | 18.7 | 16.99 | 11.25 | Upgrade
|
Retained Earnings | -245.17 | -217.35 | -189.36 | -160.69 | -129.99 | Upgrade
|
Comprehensive Income & Other | 2.74 | 5.57 | 16.84 | 4.75 | 4.57 | Upgrade
|
Shareholders' Equity | 60.42 | 31.22 | 52 | 80.62 | 97.35 | Upgrade
|
Total Liabilities & Equity | 70.23 | 43.96 | 64.42 | 86.78 | 104.6 | Upgrade
|
Total Debt | 5.12 | 7.87 | 8.23 | 1.38 | 1.68 | Upgrade
|
Net Cash (Debt) | 49.79 | 18.35 | 38.29 | 65.78 | 82.24 | Upgrade
|
Net Cash Growth | 171.40% | -52.08% | -41.79% | -20.02% | 2047.74% | Upgrade
|
Net Cash Per Share | 2.01 | 0.87 | 1.84 | 3.21 | 4.76 | Upgrade
|
Filing Date Shares Outstanding | 30.04 | 24.43 | 20.91 | 20.78 | 20.29 | Upgrade
|
Total Common Shares Outstanding | 30.04 | 21.37 | 20.88 | 20.78 | 20.21 | Upgrade
|
Working Capital | 62.5 | 35.53 | 57.84 | 72.97 | 92.93 | Upgrade
|
Book Value Per Share | 2.01 | 1.46 | 2.49 | 3.88 | 4.82 | Upgrade
|
Tangible Book Value | 60.16 | 30.73 | 51.32 | 76.49 | 92.77 | Upgrade
|
Tangible Book Value Per Share | 2.00 | 1.44 | 2.46 | 3.68 | 4.59 | Upgrade
|
Machinery | 2.27 | 2.58 | 0.54 | 1.2 | 1.83 | Upgrade
|
Leasehold Improvements | 0.54 | 0.54 | 1.84 | 0.58 | 0.55 | Upgrade
|
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.